SCHEMBL7809349

SCHEMBL7809349

COc1ccc2c(c1N=O)C(C)(C)C(=O)CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
S100A4 P26447 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 5/20 0.33
MAPT P10636 3/20 0.33
LMNA P02545 2/20 0.33
CYP3A4 P08684 2/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
GAA P10253 2/20 0.33
GLA P06280 1/20 0.33
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
ACHE P22303 1/20 0.31
HSD17B10 Q99714 1/20 0.31
OPRM1 P35372 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20004157 0.81 MEN1 (0.40) MEN1USP2S100A4KMT2AALDH1A1
SCHEMBL20366561 0.78 MEN1 (0.38) MEN1USP2S100A4KMT2AALDH1A1
SCHEMBL17448466 0.78 MEN1 (0.38) MEN1USP2S100A4KMT2AALDH1A1
SCHEMBL897309 0.78 HTR5A (0.43) MEN1USP2S100A4KMT2AALDH1A1
SCHEMBL897425 0.77 TDP1 (0.41) MEN1USP2S100A4KMT2AALDH1A1
SCHEMBL20061173 0.68 S100B (0.38) KMT2AALDH1A1MAPTLMNACYP3A4
SCHEMBL20061137 0.68 S100B (0.38) KMT2AALDH1A1MAPTLMNACYP3A4
SCHEMBL15800534 0.68 ALDH1A1 (0.44) MEN1USP2S100A4KMT2AALDH1A1
SCHEMBL20004206 0.66 ALK (0.38) MEN1KMT2AALDH1A1GAAHSD17B10
SCHEMBL20445639 0.65 KDM4E (0.46) MEN1KMT2AALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142119-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-11 US disclosed
US-20220306578-A1 TETRACYCLIC COMPOUND CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-09-29 US disclosed
EP-2441753-B1 TETRACYCLIC COMPOUND CHUGAI PHARMACEUTICAL CO LTD (JP) 2016-03-30 EP disclosed
WO-2010143664-A1 TETRACYCLIC COMPOUND 中外製薬株式会社 (JP) 2010-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142119-A1 TETRACYCLIC COMPOUND ALK, TTR, ACVR1 MEN1 994/4885USP2 4329/4885S100A4 1195/4885
US-20220306578-A1 TETRACYCLIC COMPOUND ALK, TTR, ACVR1 MEN1 994/4885USP2 4329/4885S100A4 1195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.